Home › Lung Cancer › NCT05521789
Erector Spinae Block for Thoracic Surgery
RecruitingPhase 4
Erector Spinae Blocks for Thoracic Surgery
Who can join
Ages 18 to 90 · All sexes
Full eligibility criteria
Inclusion Criteria: * pulmonary resection * 18\<age\<90 Exclusion Criteria: * pleurodesis * decortication * emergent surgery * local anesthetic allergy * intraoperative complication (inadvertent hemorrhage or conversion to open surgery) * bilateral pulmonary resection
About the study
The aim of this study is to determine if erector spinae injections with bolus infusions with local anesthetic decrease postsurgical pain and opioid consumption in patients undergoing pulmonary resection surgery.
What is being tested
- ESB Thoracic (drug)
Sponsor: George Washington University · Participants: 70 · Started: Jul 22, 2022
Contact the study team
- Eduard Shaykhinurov · Phone: 2028234259
Official record on ClinicalTrials.gov — NCT05521789
Locations in the U.S.
| District of Columbia | The George Washington University, Washington D.C. |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.